Lobbying ≠ campaign money. These LDA lobbying figures are a separate, unbridged channel from FEC campaign contributions; this platform does not yet link a lobbying registrant to any FEC committee. See the methodology glossary.
ASSOCIATION FOR CLINICAL ONCOLOGY
Lobbying registrant · 401105592
2 filings on record; a reported $690,000 in total across them. Honesty note: each amount is the registrant's reported lobbying income/spend for that quarter (a lump sum required by the Lobbying Disclosure Act, or LDA — the law governing public lobbying reports), so this total is a gross sum of quarterly figures. The filings do disclose which bills were lobbied on (below), but never how much of the money went to any one bill, and never whether the filer supported or opposed it.
Clients
Filings
| Client | Period | Reported quarterly amount | Filing type |
|---|---|---|---|
| ASSOCIATION FOR CLINICAL ONCOLOGY | Q2 2026 | $480,000 | Q2 |
| ASSOCIATION FOR CLINICAL ONCOLOGY | Q1 2026 | $210,000 | Q1 |
Source: Senate LDA filings.
Bills lobbied on
Bills named in this registrant's filings. A titled link means the bill is in our corpus; a bare canonical reference means it is not.
- us-119-hr-1262 (not in corpus)
- us-119-hr-1509 (not in corpus)
- us-119-hr-2120 (not in corpus)
- us-119-hr-2433 (not in corpus)
- us-119-hr-2484 (not in corpus)
- Improving Seniors’ Timely Access to Care Act of 2025 (us-119-hr-3514)
- us-119-hr-3521 (not in corpus)
- us-119-hr-3955 (not in corpus)
- Cancer Drug Parity Act of 2025 (us-119-hr-4101)
- us-119-hr-4191 (not in corpus)
- CONNECT for Health Act of 2025 (us-119-hr-4206)
- Protecting Patient Access to Cancer and Complex Therapies Act (us-119-hr-4299)
- us-119-hr-4425 (not in corpus)
- us-119-hr-4559 (not in corpus)
- us-119-hr-4752 (not in corpus)
- Telehealth Modernization Act (us-119-hr-5081)
- Safe Step Act (us-119-hr-5509)
- Biosimilar Red Tape Elimination Act (us-119-hr-5526)
- us-119-hr-6160 (not in corpus)
- HELP Copays Act (us-119-hr-6423)
- us-119-hr-786 (not in corpus)
- Provider Reimbursement Stability Act of 2026 (us-119-hr-8163)
- us-119-hr-8339 (not in corpus)
- us-119-hr-8622 (not in corpus)
- us-119-hr-879 (not in corpus)
- Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (us-119-hr-8839)
- us-119-hr-929 (not in corpus)
- us-119-s-1031 (not in corpus)
- us-119-s-1261 (not in corpus)
- us-119-s-1460 (not in corpus)
- us-119-s-1640 (not in corpus)
- us-119-s-1784 (not in corpus)
- us-119-s-1816 (not in corpus)
- Biosimilar Red Tape Elimination Act (us-119-s-1954)
- us-119-s-2062 (not in corpus)
- us-119-s-2287 (not in corpus)
- us-119-s-266 (not in corpus)
- us-119-s-2709 (not in corpus)
- us-119-s-2760 (not in corpus)
- us-119-s-2903 (not in corpus)
- us-119-s-4440 (not in corpus)
- us-119-s-526 (not in corpus)
- us-119-s-705 (not in corpus)
- us-119-s-752 (not in corpus)
- us-119-s-864 (not in corpus)
- us-119-s-932 (not in corpus)
Bill references are free-text extractions from LDA specific_issues;
they show a bill was named in a quarter, not money spent on it.